Takumi Yamaji

TET2 is essential for survival and hematopoietic stem cell homeostasis

Kotaro Shide, Takuro Kameda, Haruko Shimoda et al. · Leukemia · 2012 · 78 citations

Cell Therapy, Medicine, Stem Cell Mobilization +8

Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator

Takuro Kameda, Kotaro Shide, Takumi Yamaji et al. · Blood · 2014 · 77 citations · Full text

Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib

Kotaro Shide, Takuro Kameda, Takumi Yamaji et al. · Leukemia · 2016 · 71 citations · Full text

<i>TET2</i> mutation in diffuse large B-cell lymphoma

Yoko Kubuki, Takumi Yamaji, Tomonori Hidaka et al. · Journal of Clinical and Experimental Hematopathology · 2017 · 27 citations · Full text

Hematological Malignancy, Tumor Biology, Dlbcl Patients +11

TET2 Mutation in Adult T-Cell Leukemia/Lymphoma

Kazuya Shimoda, Kotaro Shide, Takuro Kameda et al. · Journal of Clinical and Experimental Hematopathology · 2015 · 20 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Atll Patients +11